The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N

Autor: Gregory R, Bluemling, Shuli, Mao, Michael G, Natchus, Wendy, Painter, Sabue, Mulangu, Mark, Lockwood, Abel, De La Rosa, Trevor, Brasel, Jason E, Comer, Alexander N, Freiberg, Alexander A, Kolykhalov, George R, Painter
Rok vydání: 2022
Zdroj: Antiviral research. 209
ISSN: 1872-9096
Popis: The unprecedented magnitude of the 2013-2016 Ebola virus (EBOV) epidemic in West Africa resulted in over 11 000 deaths and spurred an international public health emergency. A second outbreak in 2018-2020 in DRC resulted in an additional3400 cases and nearly 2300 deaths (WHO, 2020). These large outbreaks across geographically diverse regions highlight the need for the development of effective oral therapeutic agents that can be easily distributed for self-administration to populations with active disease or at risk of infection. Herein, we report the in vivo efficacy of N
Databáze: OpenAIRE